What diseases is dexmethylphenidate (Azstarys) mainly used to treat?

Dexmethylphenidate (Azstarys) is a prescription central nervous system stimulant drug primarily used to treat attention deficithyperactivity disorder (ADHD). ADHD is a common neurodevelopmental disorder, usually characterized by inattention, impulsive behavior and hyperactivity, which has a significant impact on the learning, life and social abilities of children and adolescents. Azstarys is suitable for people aged 6 years and above to help patients perform more stably and efficiently in daily life and learning by improving attention control and impulsive behavior.

Azstarys consists of two active ingredients: dexmethylphenidate and dexmethylphenidate. Dexmethylphenidate is a sustained-release ingredient that can be released slowly in the body to increase the duration of action of the drug, while dexmethylphenidate is an immediate-release ingredient that can take effect quickly. This compounded formula enables Azstarys to deliver continuous efficacy throughout the day, maintaining patients' attention levels from morning to afternoon while reducing the fluctuations in efficacy that can occur with traditional stimulants.

ADHD not only affects the academic performance of children and adolescents, but may also interfere with social interactions and daily habits. Azstarys acts on the central nervous system to increase the neurotransmission efficiency of dopamine and norepinephrine, thereby improving brain executive functions and behavioral control. This mechanism enables patients to focus better and reduce impulsive and hyperactive behaviors, resulting in better adaptability in academic, family and social environments.

Currently,Azstarys has been approved for ADHD treatment in the United States and some overseas markets and is recommended by guidelines. Its innovative compound formulation design enables the drug to ensure rapid onset of action while providing stable efficacy all day long, providing a new treatment option for ADHD patients aged 6 years and above. In the future, with the accumulation of clinical experience and research progress, Azstarys is expected to be promoted and applied in more ADHD patient groups to provide scientific and effective support for improving attention and behavioral control.

Reference materials:https://azstarys.com/